Quick Menu

Clinic Address

78 Harley Street

Contact Us

020 7034 8969
020 7034 8945



PrenatalSafe® Complete Plus

Request An Appointment

Contact information
    Phone :

    020 7034 8945
    020 7034 8969

    Email :


    Address :

    78 Harley Street
    W1G 7HJ

Prenatalsafe® Complete Plus is a blood test offered to expectant mothers as early as 10 weeks into pregnancy. It is the most comprehensive and advanced Non-Invasive Prenatal Test (NIPT) aimed to screen for a wide range of health conditions that can affect the baby. This test is offered to singleton pregnancies. In the case of vanishing twins please allow 5 weeks from the time the vanishing twin has been detected and taking this test.

  • Pregnant women from a gestational age 10 +0 weeks.
  • Singleton pregnancies
  • Natural conception or assisted conception e.g. In vitro fertilization (IVF).

The Prenatalsafe® Complete Plus test will not be offered:

  • If the expectant mother has not had ultrasound scan (to determine gestational age and pregnancy type – singleton/twins/triplets/etc.,)
  • To expectant mothers below 10 weeks gestation
  • For twin pregnancies or greater (e.g., Triplets)
  • If the mother has Down’s syndrome, or balanced translocation or mosaicism of Down’s syndrome, Edwards’ syndrome or Patau’s syndrome
  • If the mother received an organ transplantation
  • If the mother received a blood transfusion within a period of < 4months
  • If the mother received allogeneic stem cell therapy
  • If the mother has been diagnosed with a malignancy
  • If the mother has received immunotherapy, excluding intravenous immunoglobulin (IVIg) treatment

During pregnancy, the placenta sheds the baby’s (fetal) DNA into the mother’s blood. A blood sample is taken from the expectant mother. The circulating fetal DNA is isolated from the plasma component of the maternal blood and is then evaluated to determine the chance of having a baby with one of the conditions listed below.

It is important to note, that the Prenatalsafe® test is a screening test and is not a diagnostic test. If a high- chance result is obtained, the fetal medicine consultant will call you to discuss your options including diagnostic testing (chorionic villus sampling or amniocentesis).

The test will initially screen for:

  • Down Syndrome (Trisomy 21)
  • Edwards Syndrome (Trisomy 18)
  • Patau Syndrome (Trisomy 13)
  • Turner Syndrome (XO)
  • Klinefelter syndrome (XXY)
  • Jacobs Syndrome (XYY)
  • Triple X syndrome (XXX)
  • Rare Autosomal Aneuploidies = abnormalities involving all chromosomes besides 21,18,13,X and Y.
  • Deletions and Duplications in any chromosome. These are missing or gained pieces of chromosomes (>7Mb)
  • 9 different Microdeletion syndromes: 1p36 (1p36 deletion syndrome), 4p- (Wolf-Hirschhorn syndrome), 5p-(Cri-du-Chat syndrome), 15q11.2 (Prader-Willi / Angelman syndrome), 22q11.2 (DiGeorge syndrome), 8q24 (Langer-Giedion syndrome), 11q23 (Jacobsen syndrome) and 17p11.2 (Smith-Magenis syndrome)

The test will also screen for 45 ‘gene disorders’ including cystic Fibrosis, deafness, beta-thalassemia, sickle cell anaemia and other De Novo disorders. These results will be available 10 days following the initial chromosomal results.

DETECTED (High Probability/Chance)

Aneuploidy detected: indicates that the test has produced a result consistent with an aneuploidy of one (or more) of the chromosomes investigated. However, this result is not diagnostic and therefore does not guarantee that the fetus has the condition. Your consultant will call you to discuss the results in detail. The recommended follow-up is an invasive prenatal diagnosis test, such as chorionic villus sampling (CVS) or amniocentesis.

NOT-DETECTED (Low Probability/Chance)

Aneuploidy not detected: indicates that the test did not detect any aneuploidies for the chromosomes investigated. One of the major strengths of NIPT is the very high negative predictive value – which means that if you get a low chance result it is very unlikely that your baby will have one of the trisomies screened for. However, this result does not guarantee that the fetus does not carry these abnormalities.

INCONCLUSIVE RESULT (approximately 1%)

In certain cases where the sample did not pass the quality parameter thresholds, an inconclusive result is issued. In such cases, the expectant mother will likely be asked for a new blood sample in order to repeat the test. The re-test might still produce an “Inconclusive result” (in about half the cases) and a discussion with our specialist consultants is needed to determine the next steps.

The performance of the ‘chromosomal disorders’ part of the test has been assessed after looking at >71,000 pregnancies and follow-ups. This has been compiled in a document that is available upon request.

The performance of the ‘gene disorders’ part of the test is currently being reviewed and will soon be available. However, concordance with confirmatory tests for the De Novo conditions is 100% when an ultrasound finding has been detected/suspected. In the absence of ultrasound findings, concordance is observed to be ~70%.

The initial chromosome results will be available within 14 working days and one of our team members will call you as soon as the results are available and then email you a copy of the result. The 45 genetic disorders result will be ready in approximately 10 days after the initial chromosome results are available.

How much does it cost?

Please note that we are led by a team of highly skilled specialist doctors that offer diagnosis and treatment of complications which may arise in unborn babies. All your scans will be performed by our experienced fetal medicine consultants. We do not offer scans performed by sonographers or fellows. The service we provide by consultants offer screening, diagnosis and management of your pregnancy to the highest standards.

PrenatalSafe® 3 + Consultation (Consultant Led)

Includes pre-test genetic counselling and PrenatalSafe® 3 test

This option applies only if you have had a scan recently. We will ask you to bring a recent scan report (performed within 2 weeks) with the measurements of the baby.

PrenatalSafe® 3 + Scan (Consultant Led)

Includes an ultrasound scan appropriate for gestational age by our consultant specialist followed by the PrenatalSafe® 3 blood test.